Kazia Therapeutics (KZIA) Receivables - Affiliates (2025)

Kazia Therapeutics (KZIA) posted Receivables - Affiliates of $202128.1 for Q4 2025, up 249.81% on a QoQ basis from $57782.4 in Q2 2025.

Kazia Therapeutics (KZIA) Receivables - Affiliates (2025) Analysis & Trends

Kazia Therapeutics' Receivables - Affiliates history runs 1 years deep, the most recent figure standing at $202128.1 for Q4 2025.

Quarterly Receivables - Affiliates changed N/A year-over-year to $202128.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $202128.1 (changed N/A YoY) and the FY2025 annual result came in at $57782.4, changed N/A from the prior year.
Receivables - Affiliates was $202128.1 for Q4 2025 at Kazia Therapeutics, up from $57782.4 in the prior quarter.
Across five years, Receivables - Affiliates topped out at $202128.1 in Q4 2025 and bottomed at $57782.4 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables - Affiliates (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Kazia Therapeutics	4.11 Mn	4.11 Mn	-	202,128.09

Download Data